| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |